Cargando…
COVID‐19 infection and vaccination in patients with skeletal muscle channelopathies
INTRODUCTION/AIMS: Although we have gained insight into coronavirus disease‐2019 (COVID‐19) caused by severe acute respiratory syndrome–coronavirus 2 since the beginning of the pandemic, our understanding of the consequences for patients with neuromuscular disorders is evolving. In this study we aim...
Autores principales: | Vivekanandam, Vinojini, Jayaseelan, Dipa, Hanna, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537950/ https://www.ncbi.nlm.nih.gov/pubmed/36053900 http://dx.doi.org/10.1002/mus.27704 |
Ejemplares similares
-
Measuring quality of life impairment in skeletal muscle channelopathies
por: Sansone, V A, et al.
Publicado: (2012) -
Skeletal muscle Ca(V)1.1 channelopathies
por: Flucher, Bernhard E.
Publicado: (2020) -
Subacute combined degeneration of the spinal cord masking motor neuron disease: a case report
por: Loveland, Paula, et al.
Publicado: (2019) -
Sodium channelopathies of skeletal muscle result from gain or loss of function
por: Jurkat-Rott, Karin, et al.
Publicado: (2010) -
Phenotypic heterogeneity in skeletal muscle sodium channelopathies: A case report and literature review
por: Saleem, Rashid, et al.
Publicado: (2013)